Center for Scientific Review; Notice of Closed Meetings, 59799-59800 [2015-24986]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 191 / Friday, October 2, 2015 / Notices
field of use will be limited to the use of
Licensed Patent Rights for the following
Fields of Use:
and, to the extent permitted by law, will
not be released under the Freedom of
Information Act, 5 U.S.C. 552.
1. Development and Commercialization of an
ME–TARP-based therapy containing at
least one cationic lipid within the scope
of the Licensed Patent Rights.
2. Development and Commercialization of a
cell based therapeutic product with ME–
TARP for Prostate Cancer.
Dated: September 28, 2015.
Richard U. Rodriguez,
Acting Director, Office of Technology
Transfer, National Institutes of Health.
Only written comments and/or
applications for a license which are
received by the NIH Office of
Technology Transfer on or before
November 2, 2015 will be considered.
ADDRESSES: Requests for copies of the
patent application, inquiries, and
comments relating to the contemplated
exclusive license should be directed to:
Sabarni K. Chatterjee, Ph.D., M.B.A.
Senior Licensing and Patenting
Manager, NCI Technology Transfer
Center, 9609 Medical Center Drive, RM
1E530 MSC 9702, Bethesda, MD 20892–
9702 (for business mail), Rockville, MD
20850–9702; Telephone: (240) 276–
5530; Facsimile: (240) 276–5504; Email:
chatterjeesa@mail.nih.gov.
SUPPLEMENTARY INFORMATION: This
invention concerns the identification of
immunogenic peptides within TARP,
and their use to create an anti-cancer
immune response in patients. By
introducing these peptides into a
patient, an immune response against
these cancer cells can be initiated by the
peptides, resulting in treatment of the
cancer. A phase I clinical trial in stage
D0 prostate cancer patients is nearing
completion. Initial results indicate a
statistically significant decrease in the
slope of PSA for 48 weeks after
vaccination.
The technology has the potential of
being developed into a vaccine for
various cancer indications or for the
treatment of any cancer associated with
increased or preferential expression of
TARP.
The prospective exclusive license will
be royalty bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR 404.7. The prospective
exclusive license may be granted unless
within thirty (30) days from the date of
this published notice, the NIH receives
written evidence and argument that
establishes that the grant of the license
would not be consistent with the
requirements of 35 U.S.C. 209 and 37
CFR 404.7.
Complete applications for a license in
the field of use filed in response to this
notice will be treated as objections to
the grant of the contemplated exclusive
license. Comments and objections
submitted to this notice will not be
made available for public inspection
[FR Doc. 2015–24989 Filed 10–1–15; 8:45 am]
BILLING CODE 4140–01–P
mstockstill on DSK4VPTVN1PROD with NOTICES
DATES:
VerDate Sep<11>2014
20:43 Oct 01, 2015
Jkt 238001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Neurodevelopment, Synaptic
Plasticity and Neurodegeneration.
Date: October 22–23, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Embassy Row Hotel, 2015
Massachusetts Avenue NW., Washington, DC
20036.
Contact Person: Mary Schueler, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5214,
MSC 7846, Bethesda, MD 20892, 301–451–
0996, marygs@csr.nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Biobehavioral Regulation, Learning
and Ethology Study Section.
Date: October 29–30, 2015.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance New Orleans Arts
Hotel, 700 Tchoupitouls Street, New Orleans,
LA 70130.
Contact Person: Mark D. Lindner, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182,
MSC 7770, Bethesda, MD 20892, 301–435–
0913, lindnermd@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
59799
Conflict: Surgical Science and
Bioengineering.
Date: October 29, 2015.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: John Firrell, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5118,
MSC 7854, Bethesda, MD 20892, 301–435–
2598, firrellj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Medical Imaging Investigations.
Date: October 29, 2015.
Time: 11:45 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Mehrdad Mohseni, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5211,
MSC 7854, Bethesda, MD 20892, 301–435–
0484, mohsenim@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA Panel:
Molecular Probes.
Date: October 30, 2015.
Time: 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Beacon Hotel and Corporate
Quarters, 1615 Rhode Island Avenue NW.,
Washington, DC 20036.
Contact Person: Mary Custer, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4148,
MSC 7850, Bethesda, MD 20892, (301) 435–
1164, custerm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Brain Injury and Neuro-cognitive
Impairment.
Date: October 30, 2015.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Alexander Yakovlev,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5206,
MSC 7846, Bethesda, MD 20892–7846, 301–
435–1254, yakovleva@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR13–
309–311: Translational Research in Pediatric
and Obstetric, Pharmacology and
Therapeutics.
Date: October 30, 2015.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
E:\FR\FM\02OCN1.SGM
02OCN1
59800
Federal Register / Vol. 80, No. 191 / Friday, October 2, 2015 / Notices
Contact Person: Clara M. Cheng, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6170
MSC 7892, Bethesda, MD 20817, 301–435–
1041, chengc@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 28, 2015.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–24986 Filed 10–1–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2014–1053]
Towing Safety Advisory Committee;
October 2015 Meeting
Coast Guard, Department of
Homeland Security.
ACTION: Notice of Federal Advisory
Committee meeting.
AGENCY:
The Towing Safety Advisory
Committee will meet in Washington,
DC, to review and discuss
recommendations from its
subcommittees and to receive briefs
listed in the agenda under
SUPPLEMENTARY INFORMATION. All
meetings will be open to the public.
DATES: The Towing Safety Advisory
Committee Subcommittees will meet on
Thursday, October 22, 2015, from 8:30
a.m. to 5 p.m. The full Towing Safety
Advisory Committee will meet on
Friday, October 23, 2015, from 8 a.m. to
5:30 p.m. These meetings may close
early if the Committee has completed its
business.
ADDRESSES: All meetings will be held at
the Department of Transportation
Headquarters Media Center, 1200 New
Jersey Avenue SE., Washington, DC
20590. The Telephone Number for the
DOT HQ Media Center is (502) 992–
5326 and the Fax is (502) 589–4905.
You must present a form of
government issued identification to gain
entrance to the Department of
Transportation Headquarters. We
recommend you arrive at least 30
minutes before the scheduled start time.
For information on facilities or
services for individuals with disabilities
or to request special assistance at the
meeting, contact the individuals listed
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
20:43 Oct 01, 2015
Jkt 238001
in the FOR FURTHER INFORMATION
CONTACT section, as soon as possible.
To facilitate public participation, we
are inviting public comment on the
issues to be considered by the
Committee as listed in the ‘‘Agenda’’
section below. If you want the
Committee members to be able to review
your comments before the meeting,
submit them no later than October 15,
2015 and they must be identified by
Docket No. USCG–2014–1053. Written
comments may be submitted using the
Federal eRulemaking Portal at https://
www.regulations.gov. If your material
cannot be submitted using https://
www.regulations.gov, contact Mr.
Abernathy listed in the FOR FURTHER
INFORMATION CONTACT section of this
document for alternate instructions.
Instructions: All submissions received
must include the words ‘‘Department of
Homeland Security’’ and the docket
number, ‘‘USCG–2014–1053.’’ All
comments received will be posted
without alteration at https://
www.regulations.gov including any
personal information provided. You
may review a Privacy Act notice
regarding the Federal Docket
Management System in the March 24,
2005 issue of the Federal Register (70
FR 15086).
Docket: For access to the docket to
read documents or comments related to
this notice, go to https://
www.regulations.gov insert USCG–
2014–1053 in the Search box, press
Enter, and then click on the item you
wish to view.
FOR FURTHER INFORMATION CONTACT: Mr.
William J. Abernathy, Alternate
Designated Federal Officer for the
Towing Safety Advisory Committee;
Commandant (CG–OES–2), U.S. Coast
Guard, 2703 Martin Luther King Jr.
Avenue SE., Stop 7509, Washington, DC
20593–7509; telephone 202–372–1363,
fax 202–372–8382; or email
William.J.Abernathy@uscg.mil; or
Commander Jose A. Perez, Designated
Federal Officer; telephone 202–372–
1410, fax 202–372–8382; or email
Jose.A.Perez3@uscg.mil.
SUPPLEMENTARY INFORMATION: Notice of
this meeting is given under the Federal
Advisory Committee Act, 5 U.S.C.
Appendix. This Committee is
established in accordance with, and
operates under the provisions of, the
Federal Advisory Committee Act. As
stated in 33 U.S.C. 1231a, the Towing
Safety Advisory Committee provides
advice and recommendations to the
Department of Homeland Security on
matters relating to shallow-draft inland
and coastal waterway navigation and
towing safety.
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
Agenda of Meetings
The subcommittees will meet on
October 22, 2015, from 8:30 a.m. to 5
p.m., to work on their specific task
assignments:
(1) Recommendations for the
Maintenance, Repair, and Utilization of
Towing Equipment, Lines, and
Couplings.
(2) Recommendations to Establish
Criteria for Identification of Air Draft for
Towing Vessels and Tows.
(3) Recommendations concerning the
MODU KULLUK Report of
Investigation.
(4) Recommendations regarding the
automation equipment, testing, and trial
periods to be considered by Officers-inCharge, Marine Inspection for a
reduction in engine room personnel on
towing vessels.
On October 23, 2015, from 8 a.m. to
5:30 p.m., the Towing Safety Advisory
Committee will meet to discuss the
progress of its subcommittees and
expects to receive and consider the draft
final reports from the subcommittees on
the MODU KULLUK and Towing Gear.
The Committee will also receive new
tasking requesting recommendations
regarding Articulated Tug and Barge
operations and manning, and use of
Electronic Charting on Towing Vessels.
The Committee will also receive an
update on a tasking request to review
and provide recommendations regarding
engine room operations on towing
vessels equipped with systems
automation in order to determine
manning levels.
There will be a comment period for
Towing Safety Advisory Committee
members and a comment period for the
public after each report presentation,
but before each is voted on by the
Committee. The Committee will review
the information presented on each issue,
deliberate on any recommendations
presented in the Subcommittees’
reports, and formulate
recommendations for the Department’s
consideration.
A copy of each available draft report
and presentation as well as the meeting
agenda will be available by October 15,
2015, at: https://homeport.uscg.mil/tsac.
Any revisions or updates to the
presentations and the reports that are
received subsequent to the meeting will
be posted no later than 90 days
following the meeting.
An opportunity for oral comments by
the public will be provided during the
meeting on October 23, 2015. Speakers
are requested to limit their comments to
3 minutes. Please note the public oral
comment period may end before 5:30
p.m., if the Committee has finished its
E:\FR\FM\02OCN1.SGM
02OCN1
]]>Agencies
[Federal Register Volume 80, Number 191 (Friday, October 2, 2015)]
[Notices]
[Pages 59799-59800]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-24986]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Neurodevelopment, Synaptic Plasticity and
Neurodegeneration.
Date: October 22-23, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Embassy Row Hotel, 2015 Massachusetts Avenue NW.,
Washington, DC 20036.
Contact Person: Mary Schueler, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5214, MSC 7846, Bethesda, MD 20892, 301-451-
0996, marygs@csr.nih.gov.
Name of Committee: Biobehavioral and Behavioral Processes
Integrated Review Group; Biobehavioral Regulation, Learning and
Ethology Study Section.
Date: October 29-30, 2015.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Renaissance New Orleans Arts Hotel, 700 Tchoupitouls
Street, New Orleans, LA 70130.
Contact Person: Mark D. Lindner, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182, MSC 7770, Bethesda, MD
20892, 301-435-0913, lindnermd@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Surgical Science and Bioengineering.
Date: October 29, 2015.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: John Firrell, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5118, MSC 7854, Bethesda, MD 20892, 301-435-
2598, firrellj@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Medical Imaging Investigations.
Date: October 29, 2015.
Time: 11:45 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Mehrdad Mohseni, MD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5211, MSC 7854, Bethesda, MD 20892, 301-435-
0484, mohsenim@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA Panel: Molecular Probes.
Date: October 30, 2015.
Time: 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Beacon Hotel and Corporate Quarters, 1615 Rhode Island
Avenue NW., Washington, DC 20036.
Contact Person: Mary Custer, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4148, MSC 7850, Bethesda, MD 20892, (301) 435-
1164, custerm@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Brain Injury and Neuro-cognitive Impairment.
Date: October 30, 2015.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Alexander Yakovlev, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5206, MSC 7846, Bethesda, MD
20892-7846, 301-435-1254, yakovleva@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR13-309-311: Translational Research in Pediatric and
Obstetric, Pharmacology and Therapeutics.
Date: October 30, 2015.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
[[Page 59800]]
Contact Person: Clara M. Cheng, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6170 MSC 7892, Bethesda, MD
20817, 301-435-1041, chengc@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: September 28, 2015.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-24986 Filed 10-1-15; 8:45 am]
BILLING CODE 4140-01-P
